(Q36088054)

12 August 2017

1 reference

title

BLyS antagonists and peptide tolerance induction (English)

1 reference

12 August 2017

J T Merrill

1

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

14

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

204-209

1 reference

Mechanisms of deficient type I protein kinase A activity in lupus T lymphocytes

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Altered signaling triggered by ligation of the TCR/CD3 receptor in T lymphocytes from patients with systemic lupus erythematosus: the road from anergy to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

B cell abnormalities in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Dendritic cells control B cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

BCMA is essential for the survival of long-lived bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

APRIL-deficient mice have normal immune system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

A therapeutic role for BLyS antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Challenges in bringing the bench to bedside in drug development for SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Autoantibodies, lupus and the science of sabotage

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Recombinant anti-idiotypic antibodies inhibit human natural anti-glycoprotein (GP)IIb/IIIa autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Synthetic autoantigens of immunoglobulins and T-cell receptors: their recognition in aging, infection, and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

T cell-B cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Self Ig peptides that help anti-DNA antibody production: importance of charged residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2137OA

10.1191/0961203303LU2137OA

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference